Citigroup’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $248M | Buy |
|
|||||
2025
Q1 | $230M | Buy |
|
|||||
2024
Q4 | $156M | Sell |
|
|||||
2024
Q3 | $197M | Sell |
|
|||||
2024
Q2 | $170M | Buy |
|
|||||
2024
Q1 | $107M | Sell |
|
|||||
2023
Q4 | $138M | Sell |
|
|||||
2023
Q3 | $148M | Sell |
|
|||||
2023
Q2 | $160M | Buy |
|
|||||
2023
Q1 | $159M | Buy |
|
|||||
2022
Q4 | $158M | Sell |
|
|||||
2022
Q3 | $119M | Buy |
|
|||||
2022
Q2 | $109M | Sell |
|
|||||
2022
Q1 | $131M | Buy |
|
|||||
2021
Q4 | $157M | Buy |
|
|||||
2021
Q3 | $101M | Sell |
|
|||||
2021
Q2 | $114M | Sell |
|
|||||
2021
Q1 | $119M | Sell |
|
|||||
2020
Q4 | $144M | Buy |
|
|||||
2020
Q3 | $139M | Buy |
|
|||||
2020
Q2 | $135M | Sell |
|
|||||
2020
Q1 | $133M | Sell |
|
|||||
2019
Q4 | $116M | Buy |
|
|||||
2019
Q3 | $80.1M | Sell |
|
|||||
2019
Q2 | $98.7M | Sell |
|
|||||
2019
Q1 | $121M | Buy |
|
|||||
2018
Q4 | $94.1M | Sell |
|
|||||
2018
Q3 | $126M | Sell |
|
|||||
2018
Q2 | $122M | Sell |
|
|||||
2018
Q1 | $150M | Sell |
|
|||||
2017
Q4 | $146M | Buy |
|
|||||
2017
Q3 | $110M | Buy |
|
|||||
2017
Q2 | $64.6M | Sell |
|
|||||
2017
Q1 | $155M | Buy |
|
|||||
2016
Q4 | $146M | Buy |
|
|||||
2016
Q3 | $135M | Buy |
|
|||||
2016
Q2 | $98.3M | Sell |
|
|||||
2016
Q1 | $140M | Sell |
|
|||||
2015
Q4 | $233M | Buy |
|
|||||
2015
Q3 | $150M | Buy |
|
|||||
2015
Q2 | $156M | Sell |
|
|||||
2015
Q1 | $250M | Buy |
|
|||||
2014
Q4 | $137M | Buy |
|
|||||
2014
Q3 | $98.3M | Sell |
|
|||||
2014
Q2 | $141M | Sell |
|
|||||
2014
Q1 | $124M | Buy |
|
|||||
2013
Q4 | $113M | Buy |
|
|||||
2013
Q3 | $87.5M | Sell |
|
|||||
2013
Q2 | $72.3M | Buy |
|